Name | Last modified | Size | Description | |
---|---|---|---|---|
Parent Directory | - | |||
1 Economic.pdf | 29-Aug-2014 05:37 | 3.4M | ||
2 Bevacizumab.pdf | 29-Aug-2014 05:37 | 5.1M | ||
3 Prevalence.pdf | 29-Aug-2014 05:37 | 366K | ||
4 Primary.pdf | 29-Aug-2014 05:37 | 315K | ||
5 2539-2546.pdf | 29-Aug-2014 05:37 | 1.3M | ||
6 Combined.pdf | 29-Aug-2014 05:37 | 4.2M | ||
7 Bleb-Limiting.pdf | 29-Aug-2014 05:37 | 561K | ||
8 Insertion.pdf | 29-Aug-2014 05:37 | 747K | ||
9 uveal.pdf | 29-Aug-2014 05:37 | 2.4M | ||
10Paraneoplastic.pdf | 29-Aug-2014 05:37 | 407K | ||
11 Botulinum Toxin.pdf | 29-Aug-2014 05:37 | 1.6M | ||
12 Anti.pdf | 29-Aug-2014 05:37 | 1.1M | ||
13 Bannatikan.pdf | 29-Aug-2014 05:37 | 108K | ||
14 Thaybut fig color.pdf | 29-Aug-2014 05:37 | 22M | ||
Pok Jaksu 20 1.pdf | 29-Aug-2014 05:37 | 132K | ||
Saruban 20 1.pdf | 29-Aug-2014 05:37 | 164K | ||
long pok 20 1.pdf | 29-Aug-2014 05:37 | 141K | ||